ASPN
Aspen Aerogels, Inc.
ASPN lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
ASPN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Healthy | |
| Strong |
ASPN's cash flow and balance sheet are currently healthy, but its revenue and profitability are under pressure.
ASPN PE Valuation
ASPN has no meaningful PE right now: it lost money over the past year.
ASPN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect ASPN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ASPN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.57 | +$2.14 |
| Q2 2026 | -$1.52 | +$2.28 |
| Q1 2026 | -$1.35 | +$2.13 |
| Q4 2025 | -$4.73 | -2882% |
| Q3 2025 | -$3.71 | -37200% |
| Q2 2025 | -$3.80 | -$3.79 |
| Q1 2025 | -$3.48 | -$3.04 |
| Q4 2024 | $0.17 | +$0.83 |
ASPN lost $1.57 per share over the past year, a smaller loss than the year before.
ASPN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $85.2M | +17% |
| Q2 2026 | $49.8M | -36% |
| Q1 2026 | $37.9M | -52% |
| Q4 2025 | $41.3M | -66% |
| Q3 2025 | $73M | -38% |
| Q2 2025 | $78M | -34% |
| Q1 2025 | $78.7M | -17% |
| Q4 2024 | $123.1M | +46% |
ASPN's revenue is recovering but still below its 2024 peak: $85M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8.4% | -3.8 points |
| Q2 2026 | -58% | -51 points |
| Q1 2026 | -55% | +325 points |
| Q4 2025 | -170% | -182 points |
| Q3 2025 | -4.6% | -19 points |
| Q2 2025 | -6.6% | -24 points |
| Q1 2025 | -380% | -383 points |
| Q4 2024 | 12% | +10 points |
ASPN's operating margin was −8.4% last quarter, down 3.8 points from the same quarter a year ago.
ASPN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.5M | -243% |
| Q2 2026 | -$18M | -$1.2M |
| Q1 2026 | $32.8M | +$40.1M |
| Q4 2025 | $13.7M | -35% |
| Q3 2025 | $5.9M | +$6M |
| Q2 2025 | -$16.8M | +$1.2M |
| Q1 2025 | -$7.4M | +$36.2M |
| Q4 2024 | $20.9M | +$51.5M |
ASPN has burned cash in most quarters: $20M over the past year, about seven times what it generated the year before.
ASPN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +178K shares |
| 1 year | +0.8% | +670K shares |
| 3 years | +20% | +13.8M shares |
| 5 years | +191% | +54.6M shares |
| Available history | +245% | +59M shares |
ASPN has 83M diluted shares, up 0.8% from a year ago.
ASPN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -1.6x | Net Cash |
| Q3 2024 | -0.3x | Net Cash |
| Q2 2024 | -3.0x | Net Cash |
ASPN has more cash than debt.
ASPN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.7 | Neutral |
| Stochastic | 33.1 | Neutral |
ASPN's weekly RSI is 58 (neutral) and its Stochastic is 33 (neutral).
ASPN PE vs Industrials Sector
| Metric | ASPN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ASPN has no meaningful PE right now: it lost money over the past year.
ASPN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.40 | 11% above |
| 20 week MA | $5.28 | 13% above |
| 50 week MA | $4.53 | 32% above |
| 100 week MA | $5.97 | 0.3% above |
| 200 week MA | $10.3 | 42% below |
ASPN has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 42% below its 200-week average.
ASPN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.74 | $17.7 | +129% |
| 2021 | $17.7 | $50.8 | +187% |
| 2022 | $50.8 | $11.6 | -77% |
| 2023 | $11.6 | $15.8 | +36% |
| 2024 | $15.8 | $12.5 | -21% |
| 2025 | $12.5 | $2.94 | -76% |
| 2026 YTD | $2.94 | $5.99 | +104% |
ASPN's yearly returns have swung widely, from +187% in 2021 to −77% in 2022. It's up 104% so far in 2026.